Statistical Methods for Immunogenicity Assessment Statistical Methods for Immunogenicity Assessment
Chapman & Hall/CRC Biostatistics Series

Statistical Methods for Immunogenicity Assessment

Harry Yang and Others
    • $67.99
    • $67.99

Publisher Description

Develop Effective Immunogenicity Risk Mitigation StrategiesImmunogenicity assessment is a prerequisite for the successful development of biopharmaceuticals, including safety and efficacy evaluation. Using advanced statistical methods in the study design and analysis stages is therefore essential to immunogenicity risk assessment and mitigation stra

GENRE
Science & Nature
RELEASED
2015
July 17
LANGUAGE
EN
English
LENGTH
259
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
5.4
MB

More Books by Harry Yang, Jianchun Zhang, Binbing Yu & Wei Zhao

Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
Real-World Evidence in Drug Development and Evaluation
2021
Biosimilars Biosimilars
Biosimilars
2018
Clinical Trial Modernization Clinical Trial Modernization
Clinical Trial Modernization
2025
Statistical Methods in Drug Combination Studies Statistical Methods in Drug Combination Studies
Statistical Methods in Drug Combination Studies
2014
Data Science, AI, and Machine Learning in Drug Development Data Science, AI, and Machine Learning in Drug Development
Data Science, AI, and Machine Learning in Drug Development
2022
Bayesian Analysis with R for Drug Development Bayesian Analysis with R for Drug Development
Bayesian Analysis with R for Drug Development
2019

Other Books in This Series

Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
Real-World Evidence in Drug Development and Evaluation
2021
Medical Risk Prediction Models Medical Risk Prediction Models
Medical Risk Prediction Models
2021
Biomarker Analysis in Clinical Trials with R Biomarker Analysis in Clinical Trials with R
Biomarker Analysis in Clinical Trials with R
2020
Biosimilar Clinical Development: Scientific Considerations and New Methodologies Biosimilar Clinical Development: Scientific Considerations and New Methodologies
Biosimilar Clinical Development: Scientific Considerations and New Methodologies
2016
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
Innovative Methods for Rare Disease Drug Development
2020
Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
Statistical Design, Monitoring, and Analysis of Clinical Trials
2021